# Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

> **NCT00527618** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 28 (actual)

## Conditions studied

- Genital Herpes
- HIV Infection

## Interventions

- **DRUG:** valacyclovir
- **DRUG:** acyclovir

## Key facts

- **NCT ID:** NCT00527618
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527618, "Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00527618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*